Avago Technologies Ltd (AVGO) Falls 4.17% for January 18

Equities Staff |

One of the S&P 500’s big losers for Monday January 18 was Avago Technologies Ltd (AVGO). The company’s stock fell 4.17% to $119.97 on volume of 7.59 million shares.

The stock opened the day at 120.21 and traded between a low of $119.30 and a high of $123.79. The stock finished the day down $5.22 per share. Avago Technologies Ltd has an average daily volume of 3.61 million and a total float of 276.49 million shares. The 50-day SMA for Avago Technologies Ltd is $133.97 and its 200-day SMA is $128.46. The high for the stock over the last 52 weeks is $150.50 and the low is $99.16.

Avago Technologies Ltd is a designer, developer and supplier of semiconductor devices with a focus on analog III-V based products and complex digital and mixed signal complementary metal oxide semiconductor, or CMOS, based devices.

Avago Technologies Ltd is centered in Singapore, , and has 8,200 employees. Today’s trading day leaves the company with a market cap of $33.17 billionwith a P/E Ratio of 24.7. The company has a P/S ratio of 5.07, P/B ratio of 7.04, and a 21.1.

For a complete fundamental analysis analysis of Avago Technologies Ltd, check out Equities.com’s Stock Valuation Analysis report for AVGO. To see the latest independent stock recommendations from Equities.com’s analysts, visit our Research section.

The S&P 500 represents the industry standard for large-cap indices. While the Dow Jones Industrial Average (DJIA) may be the most visible stock market index in the country, the S&P 500 has long been relied on by industry insiders and fund managers as the more reliable gauge of portfolio performance.

While the DJIA is price-weighted and only includes 30 stocks, the S&P 500 uses a weighting system that factors in market cap and the size of a company’s free float while including some 500 stocks for a more comprehensive look at the broader markets’ performance. Its performance is far more representative of the large- and mega-cap stocks for any period of time.

For more news on the financial markets, go to Equities.com. Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer


Emerging Growth

Veritas Pharma Inc.

Veritas Pharma Inc, formerly Seashore Organic Medicine Inc is an emerging producer and distributor of medical marijuana.

Private Markets


Our mission is to be the best place for people who care about music to create and discover thoughtfully curated playlists. In essence, 8tracks is a platform for online mixtapes.


Trustify provides trust and safety in both the digital and physical worlds through our vast network of on-demand Private Investigators.By removing the large retainers and high hourly rates that traditional…